Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis-Reference-Cited by-同舟云学术

Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis

Published:2011-02-15 Issue:7 Volume:89 Page:817-822
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Takamura Takeyuki¹,Harama Daisuke¹,Fukumoto Suguru¹,Nakamura Yuki¹,Shimokawa Naomi¹,Ishimaru Kayoko¹,Ikegami Shuji²,Makino Seiya²,Kitamura Masanori³,Nakao Atsuhito¹

Affiliation:

1. Department of Immunology, Faculty of Medicine, University of Yamanashi Yamanashi Japan

2. Lactic Acid Bacterium Department, Food Science Institute, Division of Research and Development, Meiji Dairies Corporation Kanagawa Japan

3. Department of Molecular Signaling, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi Yamanashi Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1038/icb.2010.165

Reference25 articles.

1. The Aryl Hydrocarbon Receptor Complex

2. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein

3. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways

4. The aryl hydrocarbon receptor in immunity

5. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Limosilactobacillus reuteri strains PTA-126787 and PTA-126788 on intestinal barrier integrity and immune homeostasis in an alcohol-induced leaky gut model;Scientific Reports;2024-08-23

2. L.acidophilus HSCC LA042 and HKL suspension ameliorate DSS-induced ulcerative colitis in mice by improving the intestinal barrier inhibiting the NLRP3 inflammasome and pathogenic bacteria;Heliyon;2024-06

3. Aryl Hydrocarbon Receptor Signalling in the Control of Gut Inflammation;International Journal of Molecular Sciences;2024-04-20

4. Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis;Pharmaceuticals;2024-03-07

5. Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease;Intestinal Research;2024-01-31